By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Drug Company to Congress: The ‘Dog Ate My Homework’
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Ethics > Drug Company to Congress: The ‘Dog Ate My Homework’
Medical Ethics

Drug Company to Congress: The ‘Dog Ate My Homework’

JohnCGoodman
JohnCGoodman
Share
2 Min Read
SHARE

Just about anyone who has ever been a kid in school recalls trying to make up an excuse believable enough to avoid being punished for not turning in your homework on time. An old favorite is “the dog ate my homework.”

Just about anyone who has ever been a kid in school recalls trying to make up an excuse believable enough to avoid being punished for not turning in your homework on time. An old favorite is “the dog ate my homework.”

A decade ago WilmerHale, a powerful law firm, missed a key deadline far more important than homework. It mistakenly filed a patent extension for its drug company client one day after the 60-day deadline. Rather than being penalized one letter grade like in grade school, the patent extension was rejected by the Patent and Trademark Office, causing the client to lose patent protection five years early for a drug it owned. The drug company sued its law firm, which agreed to cough up $214 million if it cannot somehow reverse the Patent Office’s extension rejection. The powerful law firm and its client have been lobbying Congress to change the law ever since.

In an amendment that is derisively being called “The Dog Ate My Homework Act,” the House agreed to change the way the 60-day patent extension filing deadline is calculated – just to benefit this one powerful law firm and its client. The Senate takes up the debate this week. If this amendment passes, consumers will pay more and have slower access to generic drugs. Let’s hope Congress leaves the law intact rather than demonstrate that rules can be broken when they are inconvenient to powerful lobbying interests.

More Read

FDA Criticized for Lack of Controls over Increasing Prescription Narcotic Abuse
Addiction: The Road to Recovery After the Hospital
Ripping Off Medicare
4 Reasons Chris Cornell’s Death Raises Medical Ethics Questions
Corporate Social Responsibility in Healthcare
   

TAGGED:pharmaceuticalsWilmerHale
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5KFollowersLike
4.5KFollowersFollow
2.8KFollowersPin
136KSubscribersSubscribe

Latest News

health and wellness
Redefining Self-Care: Health and Wellness Beyond the Trends 
Health Uncategorized
February 28, 2026
Understanding Leaky Gut Syndrome
Understanding Leaky Gut Syndrome
Health
February 25, 2026
Invisalign for Adults: Is It Too Late to Straighten Your Teeth?
Dental health Specialties
February 24, 2026
roads are important for health
How Everyday Roads Create Lasting Health Consequences 
Health
February 24, 2026

You Might also Like

Is pharma industry too meek on pricing?

April 3, 2016

Miami Medicare Fraud Bust Easily Tops July 2010 Net

February 18, 2011

Privacy on the Internet–Tracking User History With Cookies and Flash Cookies And More-Use a Program Like CCleaner to Fight Back

February 28, 2011

The Three Cs of Physician Reputation Management

May 19, 2016
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?